{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:33:19Z","timestamp":1791469999300,"version":"4.3.4"},"reference-count":264,"publisher":"Elsevier","isbn-type":[{"value":"9780443235917","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.irn.2024.05.002","type":"book-chapter","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:58:58Z","timestamp":1719622738000},"page":"149-203","source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic potential of CBD in Autism Spectrum Disorder"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.irn.2024.05.002_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0269881107067097","article-title":"Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat","volume":"21","author":"Abdul-Monim","year":"2007","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2024.05.002_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.104","article-title":"Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder","volume":"7","author":"Ajram","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.102114","article-title":"Incidence of Clostridium perfringens and its toxin genes in the gut of children with autism spectrum disorder","volume":"61","author":"Alshammari","year":"2020","journal-title":"Anaerobe"},{"key":"10.1016\/bs.irn.2024.05.002_bib4","series-title":"Diagnostic and statistical manual of mental disorders (DSM-5\u00ae)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/bs.irn.2024.05.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2392-3-16","article-title":"Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: A randomized controlled trial","volume":"3","author":"Anagnostou","year":"2012","journal-title":"Molecular Autism"},{"key":"10.1016\/bs.irn.2024.05.002_bib6","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3390\/microorganisms10122436","article-title":"The role of the gut microbiome in psychiatric disorders","volume":"10","author":"Andrioaie","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/bs.irn.2024.05.002_bib7","doi-asserted-by":"crossref","unstructured":"Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., ... Rahman, M. M. (2008). Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. J Nat Prod, 71, 1427\u22121430. https:\/\/doi.org\/10.1021\/np8002673.","DOI":"10.1021\/np8002673"},{"key":"10.1016\/bs.irn.2024.05.002_bib8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","article-title":"Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study","volume":"49","author":"Aran","year":"2019","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/bs.irn.2024.05.002_bib9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","article-title":"Brief report: Cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems\u2014A retrospective feasibility study","volume":"49","author":"Aran","year":"2019","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2024.05.002_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13229-019-0256-6","article-title":"Lower circulating endocannabinoid levels in children with autism spectrum disorder","volume":"10","author":"Aran","year":"2019","journal-title":"Molecular Autism"},{"issue":"1","key":"10.1016\/bs.irn.2024.05.002_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13229-021-00420-2","article-title":"Cannabinoid treatment for autism: A proof-of-concept randomized trial","volume":"12","author":"Aran","year":"2021","journal-title":"Molecular Autism"},{"key":"10.1016\/bs.irn.2024.05.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2019.00424","article-title":"The endocannabinoid system as a window into microglial biology and its relationship to autism","volume":"13","author":"Araujo","year":"2019","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s10803-010-1006-y","article-title":"Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders","volume":"40","author":"Atlad\u00f3ttir","year":"2010","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2024.05.002_bib14","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1007\/s11606-020-06504-8","article-title":"Cannabidiol interactions with medications, illicit substances, and alcohol: A comprehensive review","volume":"36","author":"Balachandran","year":"2021","journal-title":"Journal of General Internal Medicine: Official Journal of the Society for Research and Education in Primary Care Internal Medicine"},{"key":"10.1016\/bs.irn.2024.05.002_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10571-020-00882-7","article-title":"Autism spectrum disorder: Signaling pathways and prospective therapeutic targets","volume":"41","author":"Baranova","year":"2021","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/bs.irn.2024.05.002_bib16","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fphar.2018.01521","article-title":"Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities","volume":"9","author":"Barchel","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.618184","article-title":"The impact of cannabidiol on human brain function: A systematic review","volume":"11","author":"Batalla","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","article-title":"Functional role of high-affinity anandamide transport, as revealed by selective inhibition","volume":"277","author":"Beltramo","year":"1997","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.irn.2024.05.002_bib19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2024.05.002_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13229-020-0313-1","article-title":"Behavioral effects of multiple-dose oxytocin treatment in autism: A randomized, placebo-controlled trial with long-term follow-up","volume":"11","author":"Bernaerts","year":"2020","journal-title":"Molecular Autism"},{"key":"10.1016\/bs.irn.2024.05.002_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NDT.S120509","article-title":"Epilepsy in patients with autism: Links, risks and treatment challenges","volume":"14","author":"Besag","year":"2018","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/bs.irn.2024.05.002_bib22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u03b4-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s42238-021-00108-7","article-title":"CBD-enriched cannabis for autism spectrum disorder: An experience of a single center in Turkey and reviews of the literature","volume":"3","author":"Bilge","year":"2021","journal-title":"Journal of Cannabis Research"},{"key":"10.1016\/bs.irn.2024.05.002_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/13623613221082710","article-title":"A randomized controlled trial into the effects of probiotics on electroencephalography in preschoolers with autism","volume":"27","author":"Billeci","year":"2023","journal-title":"Autism: The International Journal of Research and Practice"},{"key":"10.1016\/bs.irn.2024.05.002_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s42003-020-01530-y","article-title":"The antimicrobial potential of cannabidiol","volume":"4","author":"Blaskovich","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/bs.irn.2024.05.002_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0306-9877(98)90107-4","article-title":"Autism and Clostridium tetani","volume":"51","author":"B\u00f6lte","year":"1998","journal-title":"Medical Hypotheses"},{"key":"10.1016\/bs.irn.2024.05.002_bib28","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00018-018-2988-4","article-title":"The contribution of environmental exposure to the etiology of autism spectrum disorder","volume":"76","author":"B\u00f6lte","year":"2019","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/bs.irn.2024.05.002_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.molmed.2014.05.002","article-title":"Microbiota and neurodevelopmental windows: implications for brain disorders","volume":"20","author":"Borre","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/bs.irn.2024.05.002_bib30","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-3565(24)36967-8","article-title":"Regional differences in cannabinoid receptor\/G-protein coupling in rat brain","volume":"282","author":"Breivogel","year":"1997","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2024.05.002_bib31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/jcm8070989","article-title":"Potential adverse drug events and drug\u2013drug interactions with medical and consumer Cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/bs.irn.2024.05.002_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archgenpsychiatry.2011.38","article-title":"Epidemiology of autism spectrum disorders in adults in the community in England","volume":"68","author":"Brugha","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib33","first-page":"257","article-title":"Role of the cerebellum in cognitive and behavioral control: Scientific basis and investigation models","volume":"19","author":"Bugalho","year":"2006","journal-title":"Acta Medica Portuguesa"},{"key":"10.1016\/bs.irn.2024.05.002_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnbeh.2012.00073","article-title":"The endocannabinoid system: A key modulator of emotions and cognition","volume":"6","author":"Campolongo","year":"2012","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib36","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"The International Journal of Neuropsychopharmacology\/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"key":"10.1016\/bs.irn.2024.05.002_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrendo.2015.211","article-title":"Endocannabinoids--at the crossroads between the gut microbiota and host metabolism","volume":"12","author":"Cani","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/bs.irn.2024.05.002_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13229-018-0241-5","article-title":"A pilot dose finding study of pioglitazone in autistic children","volume":"9","author":"Capano","year":"2018","journal-title":"Mol Autism"},{"key":"10.1016\/bs.irn.2024.05.002_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neubiorev.2020.12.009","article-title":"Healing autism spectrum disorder with cannabinoids: A neuroinflammatory story","volume":"121","author":"Carbone","year":"2021","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/bs.irn.2024.05.002_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.biopsych.2016.10.020","article-title":"Maternal immune activation and autism spectrum disorder: From rodents to nonhuman and human primates","volume":"81","author":"Careaga","year":"2017","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/S1516-44462010000500002","article-title":"The research on marijuana in Brazil","volume":"32","author":"Carlini","year":"2010","journal-title":"Brazilian Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib42","first-page":"1","article-title":"Anticonvulsant activity of four oxygenated cannabidiol derivatives","volume":"12","author":"Carlini","year":"1975","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib43","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2024.05.002_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-psych-010213-115110","article-title":"Oxytocin Pathways and the Evolution of Human Behavior","volume":"65","author":"Carter","year":"2014","journal-title":"Annual Review of Psychology"},{"key":"10.1016\/bs.irn.2024.05.002_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behavior: Involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2013.00129","article-title":"Cannabis use during Adolescent Development: Susceptibility to Psychiatric Illness","volume":"4","author":"Chadwick","year":"2013","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2024.05.002_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2040-2392-2-10","article-title":"Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces","volume":"2","author":"Chakrabarti","year":"2011","journal-title":"Molecular Autism"},{"key":"10.1016\/bs.irn.2024.05.002_bib48","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1460-9568.2006.04697.x","article-title":"Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces","volume":"23","author":"Chakrabarti","year":"2006","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib49","first-page":"1","article-title":"Mechanisms of Action and Pharmacokinetics of Cannabis","volume":"25","author":"Chayasirisobhon","year":"2020","journal-title":"Perm J"},{"key":"10.1016\/bs.irn.2024.05.002_bib50","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1038\/s41467-020-19931-2","article-title":"Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system","volume":"11","author":"Chevalier","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/bs.irn.2024.05.002_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tics.2012.02.007","article-title":"The social motivation theory of autism","volume":"16","author":"Chevallier","year":"2012","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal ROR \u03b3 t \/ IL-17a pathway promotes autism-like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.irn.2024.05.002_bib53","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/biomedicines11082323","article-title":"Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn\u2019t","volume":"11","author":"Christensen","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/bs.irn.2024.05.002_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0304-3959(01)00454-7","article-title":"CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain","volume":"96","author":"Clayton","year":"2002","journal-title":"Pain"},{"key":"10.1016\/bs.irn.2024.05.002_bib55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/cap.2014.0112","article-title":"Relationship among glutamine, \u03b3-aminobutyric acid, and social cognition in autism spectrum disorders","volume":"25","author":"Cochran","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib56","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.neubiorev.2012.07.005","article-title":"GABA system dysfunction in autism and related disorders: From synapse to symptoms","volume":"36","author":"Coghlan","year":"2012","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/bs.irn.2024.05.002_bib57","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/nu13041346","article-title":"Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence","volume":"13","author":"Colizzi","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/bs.irn.2024.05.002_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","author":"Cravatt","year":"1996","journal-title":"Nature 7"},{"key":"10.1016\/bs.irn.2024.05.002_bib59","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): Toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2024.05.002_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2024.05.002_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbi.2018.09.003","article-title":"Palmitoylethanolamide counteracts autistic-like behaviors in BTBR T+tf\/J mice: contribution of central and peripheral mechanisms","volume":"74","author":"Cristiano","year":"2018","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.irn.2024.05.002_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.irn.2024.05.002_bib63","first-page":"1877","article-title":"The Microbiota-Gut-Brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Ver"},{"key":"10.1016\/bs.irn.2024.05.002_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ana.10557","article-title":"Maternal neuronal antibodies associated with autism and a language disorder","volume":"53","author":"Dalton","year":"2003","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2024.05.002_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bcpt.13152","article-title":"Interaction between warfarin and cannabis","volume":"124","author":"Damkier","year":"2019","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/bs.irn.2024.05.002_bib67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00702-019-02083-z","article-title":"Microbiota: a novel regulator of pain","volume":"127","author":"Defaye","year":"2020","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/bs.irn.2024.05.002_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0165-6147(94)90106-6","article-title":"New dawn of cannabinoid pharmacology","volume":"15","author":"Devane","year":"1994","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib69","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.irn.2024.05.002_bib70","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"GWPCARE3 Study Group. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.irn.2024.05.002_bib71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2020.22.3\/vdimarzo","article-title":"The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders","volume":"22","author":"Di Marzo","year":"2020","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib72","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2008.03.001","article-title":"FAAH and anandamide: is 2-AG really the odd one out?","volume":"29","author":"Di Marzo","year":"2008","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-3084(02)00150-0","article-title":"A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation","volume":"121","author":"Dinh","year":"2002","journal-title":"Chemistry and Physics of Lipids"},{"key":"10.1016\/bs.irn.2024.05.002_bib74","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bbi.2016.07.152","article-title":"Deficient Adolescent Social Behavior Following Early-Life Inflammation is Ameliorated by Augmentation of Anandamide Signaling","volume":"58","author":"Doenni","year":"2016","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.irn.2024.05.002_bib75","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.euroneuro.2008.05.003","article-title":"Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression","volume":"18","author":"Domschke","year":"2008","journal-title":"European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1208\/s12248-021-00616-7","article-title":"Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization","volume":"23","author":"Doohan","year":"2021","journal-title":"The AAPS Journal"},{"key":"10.1016\/bs.irn.2024.05.002_bib77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/glia.23738","article-title":"Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS\/NF-\u03baB-dependent signaling and glucose consumption","volume":"68","author":"Dos-Santos-Pereira","year":"2020","journal-title":"Glia"},{"key":"10.1016\/bs.irn.2024.05.002_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174338","article-title":"Gut commensal-derived butyrate reverses obesity-induced social deficits and anxiety-like behaviors via regulation of microglial homeostasis","volume":"908","author":"Duan","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/bs.irn.2024.05.002_bib79","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1098\/rspb.1998.0543","article-title":"A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain","volume":"265","author":"Egertov\u00e1","year":"1998","journal-title":"Proc Biol Sci"},{"key":"10.1016\/bs.irn.2024.05.002_bib80","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1460-9568.2004.03690.x","article-title":"Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in na\u00efve rats and in rat models of inflammatory and neuropathic pain","volume":"20","author":"Elmes","year":"2004","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib81","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/aur.239","article-title":"Global prevalence of autism and other pervasive developmental disorders","volume":"5","author":"Elsabbagh","year":"2012","journal-title":"Autism Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2024.05.002_bib83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2009.08.001","article-title":"Differential monocyte responses to TLR ligands in children with autism spectrum disorders","volume":"24","author":"Enstrom","year":"2010","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.irn.2024.05.002_bib84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00966084","article-title":"The structural and functional heterogeneity of glutamic acid decarboxylase: A review","volume":"16","author":"Erlander","year":"1991","journal-title":"Neurochemical Research"},{"key":"10.1016\/bs.irn.2024.05.002_bib85","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0006-3223(02)01430-0","article-title":"Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices","volume":"52","author":"Fatemi","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/adar.2023.11163","article-title":"Acute cannabidiol treatment enhances social interaction in adult male mice","volume":"3","author":"Ferreira","year":"2023","journal-title":"Adv Drug Alcohol Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajmg.c.31325","article-title":"Nosology and epidemiology in autism: classification counts","volume":"160","author":"Fisch","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/bs.irn.2024.05.002_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.01145","article-title":"Effects of cbd-enriched Cannabis sativa extract on autism spectrum disorder symptoms: An observational study of 18 participants undergoing compassionate use","volume":"10","author":"Fleury-Teixeira","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/bs.irn.2024.05.002_bib89","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling","volume":"135","author":"Foga\u00e7a","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib90","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1172\/JCI131752","article-title":"An endocannabinoid-regulated basolateral amygdala\u2013nucleus accumbens circuit modulates sociability","volume":"130","author":"Folkes","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.irn.2024.05.002_bib91","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s40265-019-01171-4","article-title":"Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy","volume":"79","author":"Franco","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/bs.irn.2024.05.002_bib92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0083-6729(09)81006-6","article-title":"Chapter 6 The Endocannabinoid System During Development: Emphasis on Perinatal Events and Delayed Effects","author":"Fride","year":"2009","journal-title":"Vitam Horm 81"},{"key":"10.1016\/bs.irn.2024.05.002_bib93","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/1516-4446-2020-0987","article-title":"The role of the microbiota-gut-brain axis in neuropsychiatric disorders","volume":"43","author":"Generoso","year":"2021","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib94","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/2050640617698622","article-title":"Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by\u00a0Clostridium difficile\u00a0toxin A in Caco-2 cells","volume":"5","author":"Gigli","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/bs.irn.2024.05.002_bib95","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11689-009-9023-x","article-title":"Common circuit defect of excitatory-inhibitory balance in mouse models of autism","volume":"1","author":"Gogolla","year":"2009","journal-title":"J Neurodev Disord"},{"key":"10.1016\/bs.irn.2024.05.002_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu041","article-title":"Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in Mice","volume":"18","author":"Gomes","year":"2015","journal-title":"The International Journal of Neuropsychopharmacology\/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"key":"10.1016\/bs.irn.2024.05.002_bib97","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophrenia Research"},{"key":"10.1016\/bs.irn.2024.05.002_bib98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ebcr.2017.10.001","article-title":"An interaction between warfarin and cannabidiol, a case report","volume":"9","author":"Grayson","year":"2017","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/bs.irn.2024.05.002_bib99","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2011.03.053","article-title":"Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia","volume":"222","author":"Gururajan","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib101","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41398-022-02104-8","article-title":"Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study","volume":"12","author":"Hacohen","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib102","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyy162","article-title":"Early childhood antibiotics use and autism spectrum disorders: a population-based cohort study","volume":"47","author":"Hamad","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/bs.irn.2024.05.002_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221921","article-title":"Prenatal antibiotics exposure and the risk of autism spectrum disorders: A population-based cohort study","volume":"14","author":"Hamad","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2024.05.002_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tips.2006.12.004","article-title":"The emerging functions of endocannabinoid signaling during CNS development","volume":"28","author":"Harkany","year":"2007","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2008.02.011","article-title":"Endocannabinoid functions controlling neuronal specification during brain development","volume":"286","author":"Harkany","year":"2008","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/bs.irn.2024.05.002_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109637","article-title":"Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors","volume":"94","author":"Hartmann","year":"2019","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib107","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WCO.0b013e328336a01f","article-title":"Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders","volume":"23","author":"Herbert","year":"2010","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/bs.irn.2024.05.002_bib108","first-page":"1","article-title":"TRPV1: A stress response protein in the central nervous system","volume":"1","author":"Ho","year":"2012","journal-title":"Am J Neurodegener Dis"},{"key":"10.1016\/bs.irn.2024.05.002_bib109","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s10803-013-2012-7","article-title":"Autistic traits and abnormal sensory experiences in adults","volume":"44","author":"Horder","year":"2014","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2024.05.002_bib110","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB 1 Cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2024.05.002_bib111","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.cell.2013.11.024","article-title":"Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders","volume":"155","author":"Hsiao","year":"2013","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2024.05.002_bib112","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-017-4766-7","article-title":"Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology","volume":"235","author":"Hudson","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib113","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","article-title":"Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716","volume":"58","author":"Huestis","year":"2001","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11910-018-0887-6","article-title":"The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders","volume":"18","author":"Hughes","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/bs.irn.2024.05.002_bib115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular Targets of Cannabidiol in Neurological Disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/bs.irn.2024.05.002_bib116","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/372619a0","article-title":"Endogenous cannabinoids","volume":"372","author":"Iversen","year":"1994","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2024.05.002_bib117","article-title":"Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction","volume":"9","author":"Jackson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2024.05.002_bib118","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbi.2016.06.005","article-title":"Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis","volume":"58","author":"Jiang","year":"2016","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.irn.2024.05.002_bib119","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2133\/dmpk.DMPK-12-RG-129","article-title":"Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19","volume":"28","author":"Jiang","year":"2013","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/bs.irn.2024.05.002_bib120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","article-title":"Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes","volume":"89","author":"Jiang","year":"2011","journal-title":"Life Sciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib121","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0026-895X(25)09130-8","article-title":"Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation","volume":"42","author":"Kaminski","year":"1992","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib122","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc of the Natl Acad of Sci"},{"issue":"9","key":"10.1016\/bs.irn.2024.05.002_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.169","article-title":"Endocannabinoid signaling in social functioning: an RDoC perspective","volume":"6","author":"Karhson","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2024.05.002_bib124","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13229-018-0203-y","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Molecular Autism"},{"key":"10.1016\/bs.irn.2024.05.002_bib125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.201500132","article-title":"Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPAR\u03b1","volume":"31","author":"Karwad","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/bs.irn.2024.05.002_bib126","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbr.2013.04.043","article-title":"Alterations in the endocannabinoid system in the rat valproic acid model of autism","volume":"249","author":"Kerr","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib127","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.phrs.2016.08.033","article-title":"Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid","volume":"113","author":"Kerr","year":"2016","journal-title":"Pharmacological Research"},{"key":"10.1016\/bs.irn.2024.05.002_bib128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000290040","article-title":"Prenatal lipopolysaccharide reduces social behavior in male offspring","volume":"17","author":"Kirsten","year":"2010","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/bs.irn.2024.05.002_bib129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneurol.2014.187","article-title":"Maternal immune activation and abnormal brain development across CNS disorders","volume":"10","author":"Knuesel","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.irn.2024.05.002_bib130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13567-020-00863-0","article-title":"Cannabis-derived cannabidiol and nanoselenium improve gut barrier function and affect bacterial enzyme activity in chickens subjected to C. perfringens challenge","volume":"51","author":"Konieczka","year":"2020","journal-title":"Vet Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib131","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1089\/mdr.2019.0325","article-title":"Antibiotic Resistance Genes in the Gut Microbiota of Children with Autistic Spectrum Disorder as Possible Predictors of the Disease","volume":"26","author":"Kovtun","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/bs.irn.2024.05.002_bib132","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3390\/ijms18081669","article-title":"Modulation of astrocyte activity by cannabidiol, a nonpsychoactive cannabinoid","volume":"18","author":"Kozela","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.irn.2024.05.002_bib133","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2015.11.003","article-title":"Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory\/excitatory genes in the frontal cortex of an autism model","volume":"102","author":"Kratsman","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib134","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jns.2017.08.2623","article-title":"Oral cannabis extracts as a promising treatment for the core symptoms of autism spectrum disorder: Preliminary experience in Chilean patients","volume":"381","author":"Kuester","year":"2017","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/ijms21030747","article-title":"The Endocannabinoid System: A Target for Cancer Treatment","volume":"21","author":"Laezza","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.irn.2024.05.002_bib136","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","article-title":"Autism. Autism","volume":"383","author":"Lai","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/bs.irn.2024.05.002_bib137","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib138","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib139","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fimmu.2018.00698","article-title":"Microglia and beyond: Innate immune cells as regulators of brain development and behavioral function","volume":"9","author":"Lenz","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2024.05.002_bib140","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13550280590900553","article-title":"Autistic disorder and viral infections","volume":"11","author":"Libbey","year":"2005","journal-title":"Journal of Neurovirology"},{"key":"10.1016\/bs.irn.2024.05.002_bib142","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: Role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2024.05.002_bib143","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41598-018-36430-z","article-title":"Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder","author":"Liu","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2024.05.002_bib144","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neuropharm.2018.01.041","article-title":"Involvement of glycine receptor a1 subunits in cannabinoid-induced analgesia","volume":"133","author":"Lu","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-neuro-071714-034054","article-title":"An Integrative Model of the Maturation of Cognitive Control","volume":"38","author":"Luna","year":"2015","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib146","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3390\/ijms24032389","article-title":"Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota","volume":"24","author":"Luz-Veiga","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.irn.2024.05.002_bib147","article-title":"Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay","author":"Lyall","year":"2014","journal-title":"J Autism Dev Disord 44:1546-1555"},{"key":"10.1016\/bs.irn.2024.05.002_bib148","article-title":"Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study","volume":"14","author":"Ma","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/bs.irn.2024.05.002_bib149","article-title":"Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders","volume":"23","author":"Macfabe","year":"2012","journal-title":"Microb Ecol Health Dis"},{"key":"10.1016\/bs.irn.2024.05.002_bib150","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/jnc.15321","article-title":"The neurochemistry of social reward during development: What have we learned from rodent models?","volume":"157","author":"Manduca","year":"2021","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2024.05.002_bib151","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.irn.2024.05.002_bib152","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/can.2023.0124","article-title":"Antimicrobial Effect of Cannabidiol on Intracellular\u00a0Mycobacterium tuberculosis","volume":"9","author":"Martinena","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib153","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2024.05.002_bib154","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2019.04.037","article-title":"The influence of neuroinflammation in Autism Spectrum Disorder","volume":"79","author":"Matta","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.irn.2024.05.002_bib155","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3389\/fnhum.2013.00671","article-title":"Evidence for dysregulation of axonal growth and guidance in the etiology of ASD","volume":"7","author":"McFadden","year":"2013","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/bs.irn.2024.05.002_bib156","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib157","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","article-title":"Hashish-I The structure of cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"key":"10.1016\/bs.irn.2024.05.002_bib158","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signaling.","volume":"175","author":"Melancia","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib159","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijdevneu.2019.05.006","article-title":"Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-\u03b3 agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.","volume":"76","author":"Mirza","year":"2019","journal-title":"International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib160","article-title":"Role of microbiota-derived short-chain fatty acids in nervous system disorders","volume":"139","author":"Mirzaei","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/bs.irn.2024.05.002_bib161","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcp.25518","article-title":"Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis","volume":"232","author":"Mittal","year":"2017","journal-title":"J Cell Physiol"},{"key":"10.1016\/bs.irn.2024.05.002_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1210155","article-title":"Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits","volume":"14","author":"Montagner","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib163","first-page":"103","article-title":"Molecular Targets of the Phytocannabinoids: A Complex Picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog Chem Org Nat Prod"},{"key":"10.1016\/bs.irn.2024.05.002_bib164","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira","year":"2005","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib165","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","article-title":"Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism","volume":"68","author":"Morgan","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2020.100833","article-title":"Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience","volume":"35","author":"Mostafavi","year":"2020","journal-title":"Seminars in Pediatric Neurology"},{"key":"10.1016\/bs.irn.2024.05.002_bib167","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2024.05.002_bib168","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neuroscience.2010.02.058","article-title":"Transient receptor potential vanilloid 1 channels control acetylcholine\/2-arachidonoylglicerol coupling in the striatum","volume":"167","author":"Musella","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib169","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/01.WNL.0000069463.41870.2F","article-title":"Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy","volume":"60","author":"Nabbout","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2024.05.002_bib170","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0306-4522(03)00126-X","article-title":"Selective activation of cannabinoid CB2 receptors suppresses spinal Fos protein expression and pain behavior in a rat model of inflammation","volume":"119","author":"Nackley","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib171","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/17474124.2020.1740590","article-title":"An overview of cannabis based treatment in Crohn\u2019s disease","volume":"14","author":"Naftali","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/bs.irn.2024.05.002_bib172","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/fcp.12051","article-title":"Cannabidiol reverses the mCPP-induced increase in marble-burying behavior","volume":"28","author":"Nardo","year":"2014","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib173","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/cei.13279","article-title":"Neuroimmunology \u2013 the past, present and future","volume":"197","author":"Nutma","year":"2019","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/bs.irn.2024.05.002_bib174","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ncl.2022.10.006","article-title":"Autism in Women","volume":"41","author":"Ochoa-Lubinoff","year":"2023","journal-title":"Neurol Clin"},{"key":"10.1016\/bs.irn.2024.05.002_bib176","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbi.2019.07.018","article-title":"Cannabidiol improves behavioral and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders","volume":"81","author":"Osborne","year":"2019","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.irn.2024.05.002_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109666","article-title":"Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signaling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia","volume":"95","author":"Osborne","year":"2019","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104464","article-title":"The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients","volume":"149","author":"Pagano","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib179","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1099\/jmm.0.46101-0","article-title":"Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children","volume":"54","author":"Parracho","year":"2005","journal-title":"J Med Microbiol"},{"key":"10.1016\/bs.irn.2024.05.002_bib180","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1111\/bph.15003","article-title":"Cannabidiol improves survival and behavioral co-morbidities of Dravet syndrome in mice.","volume":"177","author":"Patra","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib181","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00213-022-06196-4","article-title":"Cannabidiol for the treatment of autism spectrum disorder: hope or hype?","volume":"239","author":"Pedrazzi","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.irn.2024.05.002_bib182","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00213-015-3945-7","article-title":"Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine","volume":"232","author":"Pedrazzi","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib183","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: From THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addiction Biology"},{"key":"10.1016\/bs.irn.2024.05.002_bib184","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/mp.2015.139","article-title":"Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism","volume":"21","author":"Pilorge","year":"2016","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib185","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signaling.","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib186","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/can.2019.29014.dpi","article-title":"Waiting for the Entourage","volume":"4","author":"Piomelli","year":"2019","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib187","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pnpbp.2018.08.030","article-title":"Cannabidiol as a suggested candidate for treatment of autism spectrum disorder","volume":"8","author":"Poleg","year":"2019","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2024.05.002_bib188","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13256-020-02478-7","article-title":"A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report","volume":"14","author":"Ponton","year":"2020","journal-title":"J Med Case Rep"},{"key":"10.1016\/bs.irn.2024.05.002_bib189","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-019-0333-8","article-title":"Effects of cannabidiol on brain excitation and inhibition systems; a randomized placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder.","volume":"44","author":"Pretzsch","year":"2019","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib190","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/0269881119858306","article-title":"The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)","volume":"33","author":"Pretzsch","year":"2019","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2024.05.002_bib191","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1023\/A:1013290826504","article-title":"The Abnormal Regulation of Gene Expression in Autistic Brain Tissue","volume":"31","author":"Purcell","year":"2001","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2024.05.002_bib192","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbr.2015.05.003","article-title":"Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome","volume":"291","author":"Qin","year":"2015","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/bs.irn.2024.05.002_bib193","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/7854_2015_429","article-title":"Reward: From basic reinforcers to anticipation of social cues","volume":"30","author":"Rademacher","year":"2017","journal-title":"Current Topics in Behavioral Neurosciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib194","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-444-63233-3.00021-X","article-title":"Genetics of autism spectrum disorder","author":"Ramaswami","year":"2018","journal-title":"Handbook of Clinical Neurology 147"},{"key":"10.1016\/bs.irn.2024.05.002_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.979403","article-title":"Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report","volume":"13","author":"Raz","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib196","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR\/p70S6 Kinase Signaling Pathway","volume":"36","author":"Renard","year":"2016","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib197","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3844\/ajbbsp.2008.208.217","article-title":"Evidence of mitochondrial dysfunction in autism and implications for treatment","volume":"4","author":"Rossignol","year":"2008","journal-title":"Am J Biochem Biotechnol"},{"key":"10.1016\/bs.irn.2024.05.002_bib198","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm1521","article-title":"Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors","volume":"13","author":"Rousseaux","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.irn.2024.05.002_bib199","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: Increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes, Brain, and Behavior"},{"key":"10.1016\/bs.irn.2024.05.002_bib200","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochemical Research"},{"key":"10.1016\/bs.irn.2024.05.002_bib201","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-540-88955-7_11","article-title":"Targeting the Cannabinoid system to produce Analgesia","author":"Sagar","year":"2009","journal-title":"Curr Top Behav Neurosci 1"},{"issue":"6263","key":"10.1016\/bs.irn.2024.05.002_bib202","doi-asserted-by":"crossref","DOI":"10.1126\/science.aab3897","article-title":"Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders","volume":"350","author":"Sahin","year":"2015","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.irn.2024.05.002_bib203","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.irn.2024.05.002_bib204","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cerebral Cortex"},{"key":"10.1016\/bs.irn.2024.05.002_bib205","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41593-019-0527-8","article-title":"Autism spectrum disorder and attention deficit hyperactivity disorder have a similar burden of rare protein-truncating variants","volume":"22","author":"Satterstrom","year":"2019","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib206","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, YGPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Mol Brain Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib207","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/epi.17036","article-title":"Add-on cannabidiol in patients with Dravet syndrome: results of a long-term open-label extension trial","volume":"62","author":"Scheffer","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/bs.irn.2024.05.002_bib208","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/ani12030348","article-title":"Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint","volume":"12","author":"Schiano Moriello","year":"2022","journal-title":"Animals (Basel)"},{"issue":"1","key":"10.1016\/bs.irn.2024.05.002_bib209","first-page":"7","article-title":"Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy","volume":"9","author":"Schleider","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/bs.irn.2024.05.002_bib210","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/biomedicines10071685","article-title":"A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ","volume":"10","author":"Schnapp","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/bs.irn.2024.05.002_bib211","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","article-title":"Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse","volume":"62","author":"Schroeder","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.euroneuro.2013.11.002","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"24","author":"Schubart","year":"2014","journal-title":"European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib213","first-page":"323","article-title":"Parental Perceptions and Usage of Unlicensed Cannabidiol Products in Children With Anxiety and Neurodevelopmental Disorders","volume":"28","author":"Schwaller","year":"2023","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/bs.irn.2024.05.002_bib214","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fphar.2012.00195","article-title":"Glutamate neurocircuitry: theoretical underpinnings in schizophrenia","volume":"3","author":"Schwartz","year":"2012","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib215","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.195","article-title":"Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose","volume":"6","author":"Seeman","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib216","first-page":"F1000","article-title":"Epidiolex as adjunct therapy for treatment of refractory epilepsy: A comprehensive review with a focus on adverse effects","volume":"8","author":"Sekar","year":"2019","journal-title":"Research; a Journal of Science and its Applications"},{"key":"10.1016\/bs.irn.2024.05.002_bib217","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.182","article-title":"Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid","volume":"6","author":"Servadio","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib218","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuron.2018.11.018","article-title":"Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder","volume":"101","author":"Sgritta","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2024.05.002_bib219","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.gastro.2016.04.015","article-title":"The Role of the Endocannabinoid System in the Brain-Gut Axis","volume":"151","author":"Sharkey","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.irn.2024.05.002_bib220","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar2016","article-title":"Microbiota and the social brain","volume":"366","author":"Sherwin","year":"2019","journal-title":"Science"},{"key":"10.1016\/bs.irn.2024.05.002_bib221","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13041-017-0318-7","article-title":"The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress","volume":"10","author":"Shi","year":"2017","journal-title":"Mol Brain"},{"key":"10.1016\/bs.irn.2024.05.002_bib222","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/can.2021.0224","article-title":"The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder","volume":"8","author":"Siani-Rose","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib223","article-title":"Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors","volume":"156","author":"Silva","year":"2020","journal-title":"Pharmacological Research: the Official Journal of the Italian Pharmacological Society"},{"key":"10.1016\/bs.irn.2024.05.002_bib224","article-title":"Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial","author":"Silva","year":"2022","journal-title":"Trends Psychiatry Psychotherapy 26:44"},{"key":"10.1016\/bs.irn.2024.05.002_bib225","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.585096","article-title":"Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis","volume":"11","author":"Silvestri","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.irn.2024.05.002_bib226","article-title":"Does the \u201cEntourage Effect\u201d in Cannabinoids Exist? A Narrative Scoping Review","author":"Simei","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib227","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/480289","article-title":"Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?","volume":"2012","author":"Siniscalco","year":"2012","journal-title":"Journal of Biomedicine & Biotechnology"},{"key":"10.1016\/bs.irn.2024.05.002_bib228","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1007\/s10803-013-1824-9","article-title":"Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders","volume":"43","author":"Siniscalco","year":"2013","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2024.05.002_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187926","article-title":"Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans","volume":"12","author":"Smith","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2024.05.002_bib230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbi.2018.09.014","article-title":"Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPAR\u03b3 receptors","volume":"74","author":"Sonego","year":"2018","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.irn.2024.05.002_bib231","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fpsyt.2021.630247","article-title":"The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review","volume":"12","author":"Sorkhou","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib232","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2017.00020","article-title":"Sensory, emotional and cognitive contributions to anxiety in autism spectrum disorders","volume":"11","author":"South","year":"2017","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/bs.irn.2024.05.002_bib233","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1185737","article-title":"Cannabidiol and Cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder","volume":"17","author":"Staben","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/bs.irn.2024.05.002_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114004","article-title":"Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment","volume":"177","author":"Stark","year":"2020","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib235","doi-asserted-by":"crossref","first-page":"395","DOI":"10.31887\/DCNS.2017.19.4\/rfindling","article-title":"Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents","volume":"19","author":"Stepanova","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/bs.irn.2024.05.002_bib236","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","article-title":"The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?","volume":"99","author":"Stilling","year":"2016","journal-title":"Neurochem Int"},{"key":"10.1016\/bs.irn.2024.05.002_bib237","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.irn.2024.05.002_bib238","first-page":"49","article-title":"Microglial activation in young adults with autism spectrum disorder","volume":"70","author":"Suzuki","year":"2013","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.irn.2024.05.002_bib239","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.ne.06.030183.001413","article-title":"Hypothalamic Integration: Organization of the Paraventricular and Supraoptic Nuclei","volume":"6","author":"Swanson","year":"1983","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib240","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/epi.17150","article-title":"Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial","volume":"63","author":"Thiele","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/bs.irn.2024.05.002_bib241","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib242","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neubiorev.2021.07.023","article-title":"Neuroinflammation in autism spectrum disorders: Exercise as a \u201cpharmacological\u201d tool","volume":"Ver 129","author":"Toscano","year":"2021","journal-title":"Neurosci Biobehav"},{"key":"10.1016\/bs.irn.2024.05.002_bib243","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0269881109106925","article-title":"Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"25","author":"Valvassori","year":"2011","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/bs.irn.2024.05.002_bib244","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2024.05.002_bib245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2018.07.029","article-title":"Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome","volume":"140","author":"Vigli","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib246","first-page":"878","article-title":"Therapies for Children With Autism Spectrum Disorders","volume":"85","author":"Warren","year":"2011","journal-title":"Comparative Effectiveness Reviews"},{"key":"10.1016\/bs.irn.2024.05.002_bib247","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mcn.2008.02.001","article-title":"The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation","volume":"38","author":"Watson","year":"2008","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib248","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tins.2017.04.005","article-title":"Endocannabinoid signaling in the control of social behavior","volume":"40","author":"Wei","year":"2017","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib249","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/can.2015.0008","article-title":"Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment","volume":"1","author":"Wei","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/bs.irn.2024.05.002_bib250","doi-asserted-by":"crossref","first-page":"14084","DOI":"10.1073\/pnas.1509795112","article-title":"Endocannabinoid signaling mediates oxytocin-driven social reward","volume":"112","author":"Wei","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2024.05.002_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-neuro-080317-061747","article-title":"Abnormal mTOR activation in autism","volume":"41","author":"Winden","year":"2018","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib252","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1023\/A:1025023131029","article-title":"Possible association between congenital cytomegalovirus infection and autistic disorder","volume":"33","author":"Yamashita","year":"2003","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/bs.irn.2024.05.002_bib253","article-title":"Causal atlas between inflammatory bowel disease and mental disorders: A bi-directional 2-sample Mendelian randomization study","volume":"14","author":"Yang","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2024.05.002_bib254","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.aaa8120","article-title":"Can oxytocin treat autism?","volume":"347","author":"Young","year":"2015","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.irn.2024.05.002_bib255","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/ijms18091916","article-title":"The endocannabinoid system and autism spectrum disorders: Insights from animal models","volume":"18","author":"Zamberletti","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2024.05.002_bib256","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/0269881119844184","article-title":"Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male\u00a0Mecp2\u00a0mutant mice","volume":"33","author":"Zamberletti","year":"2019","journal-title":"J Psychopharmacol"},{"key":"10.1016\/bs.irn.2024.05.002_bib257","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389200217666151210142051","article-title":"Cannabinoids and cytochrome P450 interactions","volume":"17","author":"Zendulka","year":"2016","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/bs.irn.2024.05.002_bib258","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2024.05.002_bib259","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/dmcn.15072","article-title":"Efficacy and safety of antiseizure medication for Lennox Gastaut syndrome: A systematic review and network meta-analysis","volume":"64","author":"Zhang","year":"2022","journal-title":"Developmental Medicine & Child Neurology"},{"key":"10.1016\/bs.irn.2024.05.002_bib260","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","article-title":"Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis","volume":"39","author":"Zhang","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/bs.irn.2024.05.002_bib261","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib262","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"Journal of Psychopharmacoly"},{"key":"10.1016\/bs.irn.2024.05.002_bib263","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by \u03b49-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2024.05.002_bib264","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1542\/peds.2014-3667D","article-title":"Early screening of autism spectrum disorder: Recommendations for practice and research","volume":"136","author":"Zwaigenbaum","year":"2015","journal-title":"Pediatrics"}],"container-title":["International Review of Neurobiology","Cannabidiol in Neurology and Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774224000709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774224000709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:52:08Z","timestamp":1754409128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774224000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443235917"],"references-count":264,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2024.05.002","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}